PAINREFORM

painreform-logo

PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory pathway, PainReform applies unique technologies to enhance efficacy, reduce adverse effects and increase convenience as well as faster return of motor function.

#People #Website #More

PAINREFORM

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2007-01-01

Address:
Herzliya, Tel Aviv, Israel

Country:
Israel

Website Url:
http://www.painreform.com

Total Employee:
1+

Status:
Active

Contact:
97299542266

Email Addresses:
[email protected]

Total Funding:
6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins



Current Advisors List

ilan-neugarten_image

Ilan Neugarten Board of Directors @ PainReform
Board_member

Current Employees Featured

sigal-aviel_image

Sigal Aviel
Sigal Aviel COO @ PainReform
COO
2014-10-01

ilan-hadar_image

Ilan Hadar
Ilan Hadar Chief Executive Officer @ PainReform
Chief Executive Officer
2020-11-01

lihu-avitov_image

Lihu Avitov
Lihu Avitov Co-Founder @ PainReform
Co-Founder
2008-01-01

eli-hazum_image

Eli Hazum
Eli Hazum CEO @ PainReform
CEO
2012-01-01

Founder


lihu-avitov_image

Lihu Avitov

Official Site Inspections

http://www.painreform.com

Unable to get host informations!!!

Loading ...

More informations about "PainReform"

company-profile - painreform

Company profile We are a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics Our proprietary extended-release drug-delivery โ€ฆSee details»

Investors - painreform

5 days ago Investor relations We are a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics Our proprietary extended release drug-delivery system is designed to provide an extended โ€ฆSee details»

PainReform - Crunchbase Company Profile & Funding

PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory โ€ฆSee details»

PainReform Ltd. (PRFX) Company Profile & Facts - Yahoo Finance

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in โ€ฆSee details»

PainReform (PRFX) Company Profile & Description - Stock Analysis

4 days ago PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical โ€ฆSee details»

PainReform - Org Chart, Teams, Culture & Jobs - The Org

PainReform. Join to edit. Join to edit. PainReform Ltd is a phamaceutical company that specializes in the reformulation of current pain medications to benefit the patient better. โ€ฆSee details»

PainReform - Israeli Startup | Startup Nation Finder

Mar 6, 2025 PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics. Its proprietary drug-delivery system is designed to โ€ฆSee details»

PainReform - 2025 Company Profile, Funding & Competitors

Mar 5, 2025 Painreform is a specialty pharmaceutical company that develops products for the treatment of pain. It is focused on reformulations of established pain drugs by applying unique โ€ฆSee details»

PainReform - businessabc

Mar 20, 2025 PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in โ€ฆSee details»

PainReform - Products, Competitors, Financials, Employees, โ€ฆ

PainReform is a clinical stage specialty pharmaceutical company involved in the reformulation of established therapeutics within the pain management sector. Use the CB Insights Platform to โ€ฆSee details»

PainReform Provides Year-End Business Update; on Track to โ€ฆ

Mar 17, 2022 PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022 โ€ฆSee details»

PainReform 2025 Company Profile: Stock Performance & Earnings

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the โ€ฆSee details»

PainReform - Craft

PainReform is a pharmaceutical company that develops products for the treatment of pain. Its extended release drug-delivery system is designed to provide an extended period of post โ€ฆSee details»

PainReform - Overview, News & Similar companies | ZoomInfo.com

Jun 15, 2023 PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics. PRF-110, the Company's lead product, is based on โ€ฆSee details»

PainReform Provides Year-End Business Update; On track to โ€ฆ

Tel Aviv, Israel โ€“ March 17, 2022 โ€“ PainReform Ltd. (Nasdaq: PRFX) (โ€œPainReformโ€ or the โ€œCompanyโ€), a clinical-stage specialty pharmaceutical company focused on the reformulation โ€ฆSee details»

PainReform Provides Year-End Business Update and Reports

Mar 18, 2021 Ilan Hadar, Chief Executive Officer of PainReform, commented, โ€œWe are making rapid progress towards commencing our Phase 3 clinical trials of PRF-110. Our first planned โ€ฆSee details»

Possible New Era in Pain Management: FDA Approves Novel Non โ€ฆ

Apr 15, 2025 The Institute for Clinical and Economic Review, a nonprofit organization that evaluates prescription drug cost-effectiveness, has suggested that the drug could be only โ€ฆSee details»

PainReform Provides Business Update for the Third Quarter of โ€ฆ

Reports continued progress towards commencing Phase 3 clinical trials. Announces Selection of Pharmaceutics International, Inc. as U.S. Manufacturer of PRF-110 for Upcoming Phase 3 โ€ฆSee details»

Inside the Battle Over OpenAIโ€™s Corporate Restructuring

5 days ago Aguilarโ€™s new organization, LatinoProsperity, focuses on intergenerational wealth building, and he believed cutting-edge AI chatbots such as ChatGPT would become an โ€ฆSee details»

press releases - painreform

Nov 20, 2024 PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics. read more. 02/18/2025. PainReform Executes โ€ฆSee details»